Naloxone is a fantastic tool in reducing opioid deaths, but gentler versions would be helpful for fighting overdose ...
The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.
The zebrafish has gained increasing recognition as a valuable vertebrate model in biomedical research. Its powerful genetic toolkit, coupled with ...